A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer

Journal of Cancer Research and Clinical Oncology

Volumn 142, Issue 4, 2016, Pages 813-821

  Wang, Yu ^a   Lin, Yong ^a   Zhang, Hui guo ^a   Zhu, Jing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

5 Aminolevulinic acid; Combined photodynamic therapy; Hematoporphyrin derivative; Photosensitive period; Photosensitizer

Indexed keywords

AMINOLEVULINIC ACID; HEMATOPORPHYRIN DERIVATIVE; ANTINEOPLASTIC AGENT; PHOTOSENSITIZING AGENT;

ABLATION THERAPY; ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER REGRESSION; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; LIGHT EXPOSURE; MALE; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOTOXICITY; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOMA; SYSTEMIC THERAPY; TUMOR RECURRENCE; WOUND HEALING; ADVERSE EFFECTS; AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; FLUORESCENCE; INTRAVENOUS DRUG ADMINISTRATION; LIGHT; LOW LEVEL LASER THERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; REMISSION; RETROSPECTIVE STUDY; SKIN NEOPLASMS; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AGED; AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FLUORESCENCE; HEMATOPORPHYRIN DERIVATIVE; HUMANS; INJECTIONS, INTRAVENOUS; LASER THERAPY; LIGHT; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84961176627     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-015-2066-3     Document Type: Article

References (24)

1. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J (2011) Photodynamic therapy of cancer: an update. CA Cancer J Clin 61(4):250–281
2. Ahmadi S, McCarron PA, Donnelly RF, Woolfson AD, McKenna K (2004) Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study. Exp Dermatol 13(7):445–451
3. Basset-Seguin N, Ibbotson SH, Emtestam L, Tarstedt M, Morton C, Maroti M, Calzavara-Pinton P, Varma S, Roelandts R, Wolf P (2008) Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 18:547–553
4. Capella MA, Capella LS (2003) A light in multidrug resistance: photodynamic treatment of multidrug-resistant tumors. J Biomed Sci 10(4):361–366
5. Casas A, Fukuda H, Di Venosa G, Batlle AM (2000) The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization. Br J Dermatol 143(3):564–572
6. Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3(5):380–387
7. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90(12):889–905
8. Dugan M, Crawford E, Nseyo U (1991) Photodynamic therapy (PDT) after transurethral resection (tur) for superficial papillary bladder carcinoma (SBC): a randomized trial. Proc ASCO 10:173
9. Edell ES, Cortese DA (1992) Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 102:1319–1322
10. Hopper C, Kubler A, Lewis H, Tan IB, Putnam G (2004) mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int J Cancer 111:138–146
11. Kato H, Okunaka T, Shimatani H (1996) Photodynamic therapy for early stage bronchogenic carcinoma. J Clin Laser Med Surg 14:235–238
12. Kaviani A, Ataie-Fashtami L, Fateh M, Sheikhbahaee N, Ghodsi M, Zand N, Djavid GE (2005) Photodynamic therapy of head and neck basal cell carcinoma according to different clinicopathologic features. Lasers Surg Med 36:377–382
13. Kennedy JC, Pottier RH (1992) Endogenous protoporphyrin IX, a clinical useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14:275–292
14. Kennedy JC, Pottier RH, Pross DC (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6:143–148
15. Kennedy JC, Marcus SL, Pottier RH (1996) Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J Clin Laser Med Surg 14:289–304
16. Kostron H (2010) Photodynamic Diagnosis and Therapy and the Brain. In: Gomer CJ (ed) Photodynamic Therapy, Methods in Molecular Biology. Springer Science + Business Media, LLC, pp 261–280
17. Lightdale CJ, Heier SK, Marcon NE, McCaughan JS Jr, Gerdes H, Overholt BF, Sivak MV Jr, Stiegmann GV, Nava HR (1995) Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 42:507–512
18. Mroz P, Yaroslavsky A, Kharkwal GB, Hamblin MR (2011) Cell death pathways in photodynamic therapy of cancer. Cancers 3:2516–2539
19. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM (1997) 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer 79:2282–2308
20. Vrouenraets MB, Visser GW, Snow GB, van Dongen GA (2003) Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res 23(1B):505–522
21. Zeitouni NC, Shieh S, Oseroff AR (2001) Laser and photodynamic therapy in the management of cutaneous malignancies. Clin Dermatol 19(3):328–338
22. Zhu J, Yang XJ, Long Y et al (1999) Clinical study of fluorescence induced by small dose of hematoporphyrin for diagnosing tumor. Shanghai Di-er Yike Daxue Xuebao S(19);76:77
23. Zhu J, Yan M, Zhang HG et al (2004) Research of ALA combined with HpD-PDT which induced S180 ascitic tumor cells, death or apoptosis on cytology. App Laser 24(5):301–306
24. Zhu J, Yan M, Zhang HG et al (2005) Research of ALA combined with HpD-PDT in treatment of S180 sarcoma of rats. App Laser 25(1):53–61